nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—PTGS2—head and neck cancer	0.224	1	CbGaD
Indomethacin—ABCC6—Vinblastine—head and neck cancer	0.136	0.255	CbGbCtD
Indomethacin—ABCC3—Fluorouracil—head and neck cancer	0.0704	0.132	CbGbCtD
Indomethacin—SLC22A7—Fluorouracil—head and neck cancer	0.055	0.103	CbGbCtD
Indomethacin—ABCC4—Fluorouracil—head and neck cancer	0.0538	0.101	CbGbCtD
Indomethacin—SLC22A7—Docetaxel—head and neck cancer	0.042	0.079	CbGbCtD
Indomethacin—ABCC1—Vinblastine—head and neck cancer	0.04	0.0752	CbGbCtD
Indomethacin—ABCC1—Docetaxel—head and neck cancer	0.033	0.062	CbGbCtD
Indomethacin—ABCC2—Vinblastine—head and neck cancer	0.0296	0.0557	CbGbCtD
Indomethacin—ABCC2—Docetaxel—head and neck cancer	0.0244	0.0459	CbGbCtD
Indomethacin—ALB—Fluorouracil—head and neck cancer	0.0199	0.0375	CbGbCtD
Indomethacin—CYP2C9—Fluorouracil—head and neck cancer	0.0107	0.0202	CbGbCtD
Indomethacin—ABCB1—Vinblastine—head and neck cancer	0.00966	0.0182	CbGbCtD
Indomethacin—ABCB1—Docetaxel—head and neck cancer	0.00796	0.015	CbGbCtD
Indomethacin—Necrotising enterocolitis neonatal—Docetaxel—head and neck cancer	0.00492	0.0516	CcSEcCtD
Indomethacin—Necrotizing enterocolitis—Docetaxel—head and neck cancer	0.00492	0.0516	CcSEcCtD
Indomethacin—Necrotising colitis—Docetaxel—head and neck cancer	0.00403	0.0422	CcSEcCtD
Indomethacin—Leukaemia—Hydroxyurea—head and neck cancer	0.00332	0.0347	CcSEcCtD
Indomethacin—Distress—Hydroxyurea—head and neck cancer	0.00322	0.0337	CcSEcCtD
Indomethacin—CES1—larynx—head and neck cancer	0.00303	0.0661	CbGeAlD
Indomethacin—AKR1C3—Vincristine—Vinblastine—head and neck cancer	0.00266	1	CbGdCrCtD
Indomethacin—Proctitis—Fluorouracil—head and neck cancer	0.00263	0.0276	CcSEcCtD
Indomethacin—Emotional distress—Hydroxyurea—head and neck cancer	0.0021	0.022	CcSEcCtD
Indomethacin—PLA2G2A—tongue—head and neck cancer	0.00202	0.044	CbGeAlD
Indomethacin—GLO1—hair follicle—head and neck cancer	0.00186	0.0405	CbGeAlD
Indomethacin—PTGR2—saliva-secreting gland—head and neck cancer	0.00158	0.0343	CbGeAlD
Indomethacin—Emotional distress—Fluorouracil—head and neck cancer	0.00151	0.0158	CcSEcCtD
Indomethacin—Platelet count decreased—Hydroxyurea—head and neck cancer	0.0015	0.0157	CcSEcCtD
Indomethacin—Peptic ulcer—Vinblastine—head and neck cancer	0.00146	0.0153	CcSEcCtD
Indomethacin—Parkinsonism—Fluorouracil—head and neck cancer	0.00141	0.0148	CcSEcCtD
Indomethacin—Ileus—Vinblastine—head and neck cancer	0.00138	0.0145	CcSEcCtD
Indomethacin—PLA2G2A—mouth—head and neck cancer	0.00136	0.0296	CbGeAlD
Indomethacin—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00132	0.0139	CcSEcCtD
Indomethacin—Disseminated intravascular coagulation—Docetaxel—head and neck cancer	0.0013	0.0136	CcSEcCtD
Indomethacin—Rectal haemorrhage—Vinblastine—head and neck cancer	0.00108	0.0114	CcSEcCtD
Indomethacin—PPARA—neck—head and neck cancer	0.00108	0.0236	CbGeAlD
Indomethacin—Tenderness—Hydroxyurea—head and neck cancer	0.00102	0.0107	CcSEcCtD
Indomethacin—GLO1—parotid gland—head and neck cancer	0.00102	0.0221	CbGeAlD
Indomethacin—GLO1—saliva-secreting gland—head and neck cancer	0.000973	0.0212	CbGeAlD
Indomethacin—PTGR2—thyroid gland—head and neck cancer	0.000961	0.021	CbGeAlD
Indomethacin—Bromfenac—PTGS2—head and neck cancer	0.000949	0.327	CrCbGaD
Indomethacin—Ulcer—Hydroxyurea—head and neck cancer	0.000944	0.00989	CcSEcCtD
Indomethacin—Heartburn—Fluorouracil—head and neck cancer	0.000934	0.00979	CcSEcCtD
Indomethacin—PLA2G2A—saliva-secreting gland—head and neck cancer	0.000905	0.0197	CbGeAlD
Indomethacin—PTGS2—cartilage tissue—head and neck cancer	0.000877	0.0191	CbGeAlD
Indomethacin—PTGR2—head—head and neck cancer	0.000853	0.0186	CbGeAlD
Indomethacin—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000853	0.00893	CcSEcCtD
Indomethacin—GLO1—epithelium—head and neck cancer	0.000849	0.0185	CbGeAlD
Indomethacin—Bezafibrate—CYP1A1—head and neck cancer	0.000839	0.289	CrCbGaD
Indomethacin—PLA2G2A—connective tissue—head and neck cancer	0.000831	0.0181	CbGeAlD
Indomethacin—ABCC6—connective tissue—head and neck cancer	0.000823	0.0179	CbGeAlD
Indomethacin—CES1—neck—head and neck cancer	0.000804	0.0175	CbGeAlD
Indomethacin—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.000795	0.00833	CcSEcCtD
Indomethacin—Deafness—Vinblastine—head and neck cancer	0.000795	0.00833	CcSEcCtD
Indomethacin—PLA2G2A—epithelium—head and neck cancer	0.000789	0.0172	CbGeAlD
Indomethacin—PPARA—connective tissue—head and neck cancer	0.000777	0.0169	CbGeAlD
Indomethacin—GLO1—trachea—head and neck cancer	0.000751	0.0164	CbGeAlD
Indomethacin—PPARA—epithelium—head and neck cancer	0.000737	0.0161	CbGeAlD
Indomethacin—Tenderness—Fluorouracil—head and neck cancer	0.000737	0.00772	CcSEcCtD
Indomethacin—AKR1C3—parotid gland—head and neck cancer	0.000733	0.016	CbGeAlD
Indomethacin—PLA2G2A—trachea—head and neck cancer	0.000698	0.0152	CbGeAlD
Indomethacin—CXCL8—trachea—head and neck cancer	0.000691	0.0151	CbGeAlD
Indomethacin—ABCC1—hair follicle—head and neck cancer	0.000688	0.015	CbGeAlD
Indomethacin—Ulcer—Fluorouracil—head and neck cancer	0.00068	0.00712	CcSEcCtD
Indomethacin—Dysarthria—Fluorouracil—head and neck cancer	0.00068	0.00712	CcSEcCtD
Indomethacin—Heartburn—Docetaxel—head and neck cancer	0.000674	0.00706	CcSEcCtD
Indomethacin—Ileus—Docetaxel—head and neck cancer	0.000656	0.00687	CcSEcCtD
Indomethacin—GLO1—lymphoid tissue—head and neck cancer	0.000654	0.0143	CbGeAlD
Indomethacin—Tolmetin—PTGS2—head and neck cancer	0.000638	0.219	CrCbGaD
Indomethacin—PLA2G2A—lymphoid tissue—head and neck cancer	0.000608	0.0132	CbGeAlD
Indomethacin—PTGR2—lymph node—head and neck cancer	0.000597	0.013	CbGeAlD
Indomethacin—PPARG—neck—head and neck cancer	0.000596	0.013	CbGeAlD
Indomethacin—GLO1—thyroid gland—head and neck cancer	0.000594	0.0129	CbGeAlD
Indomethacin—Coma—Fluorouracil—head and neck cancer	0.000587	0.00615	CcSEcCtD
Indomethacin—Pancytopenia—Vinblastine—head and neck cancer	0.000583	0.00611	CcSEcCtD
Indomethacin—CES1—connective tissue—head and neck cancer	0.000576	0.0126	CbGeAlD
Indomethacin—PPARA—lymphoid tissue—head and neck cancer	0.000568	0.0124	CbGeAlD
Indomethacin—PLA2G2A—thyroid gland—head and neck cancer	0.000552	0.012	CbGeAlD
Indomethacin—ABCC6—thyroid gland—head and neck cancer	0.000547	0.0119	CbGeAlD
Indomethacin—Depression—Vinblastine—head and neck cancer	0.000546	0.00572	CcSEcCtD
Indomethacin—AKR1C3—trachea—head and neck cancer	0.000542	0.0118	CbGeAlD
Indomethacin—Thrombophlebitis—Fluorouracil—head and neck cancer	0.000539	0.00565	CcSEcCtD
Indomethacin—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000537	0.00563	CcSEcCtD
Indomethacin—Pancytopenia—Hydroxyurea—head and neck cancer	0.000532	0.00557	CcSEcCtD
Indomethacin—GLO1—head—head and neck cancer	0.000527	0.0115	CbGeAlD
Indomethacin—PPARA—thyroid gland—head and neck cancer	0.000516	0.0112	CbGeAlD
Indomethacin—Agranulocytosis—Vinblastine—head and neck cancer	0.000511	0.00536	CcSEcCtD
Indomethacin—Weight increased—Hydroxyurea—head and neck cancer	0.00051	0.00534	CcSEcCtD
Indomethacin—Oliguria—Docetaxel—head and neck cancer	0.000503	0.00527	CcSEcCtD
Indomethacin—Drowsiness—Hydroxyurea—head and neck cancer	0.0005	0.00523	CcSEcCtD
Indomethacin—Haemoglobin—Vinblastine—head and neck cancer	0.000494	0.00518	CcSEcCtD
Indomethacin—Haemorrhage—Vinblastine—head and neck cancer	0.000492	0.00515	CcSEcCtD
Indomethacin—PLA2G2A—head—head and neck cancer	0.00049	0.0107	CbGeAlD
Indomethacin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00049	0.00513	CcSEcCtD
Indomethacin—Stomatitis—Hydroxyurea—head and neck cancer	0.000487	0.0051	CcSEcCtD
Indomethacin—ABCC6—head—head and neck cancer	0.000485	0.0106	CbGeAlD
Indomethacin—Naproxen—PTGS2—head and neck cancer	0.00048	0.165	CrCbGaD
Indomethacin—Osteoarthritis—Fluorouracil—head and neck cancer	0.000467	0.00489	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.000467	0.00489	CcSEcCtD
Indomethacin—PPARA—head—head and neck cancer	0.000458	0.00997	CbGeAlD
Indomethacin—Haemoglobin—Hydroxyurea—head and neck cancer	0.000451	0.00472	CcSEcCtD
Indomethacin—Haemorrhage—Hydroxyurea—head and neck cancer	0.000448	0.0047	CcSEcCtD
Indomethacin—Colitis—Docetaxel—head and neck cancer	0.000445	0.00467	CcSEcCtD
Indomethacin—Skin exfoliation—Docetaxel—head and neck cancer	0.000443	0.00464	CcSEcCtD
Indomethacin—Fluid retention—Docetaxel—head and neck cancer	0.00044	0.00461	CcSEcCtD
Indomethacin—SLC10A1—head—head and neck cancer	0.00044	0.00959	CbGeAlD
Indomethacin—Alopecia—Vinblastine—head and neck cancer	0.000435	0.00455	CcSEcCtD
Indomethacin—AKR1C3—thyroid gland—head and neck cancer	0.000429	0.00934	CbGeAlD
Indomethacin—PPARG—connective tissue—head and neck cancer	0.000427	0.00931	CbGeAlD
Indomethacin—CES1—lymphoid tissue—head and neck cancer	0.000421	0.00918	CbGeAlD
Indomethacin—Lightheadedness—Docetaxel—head and neck cancer	0.000415	0.00435	CcSEcCtD
Indomethacin—Pulmonary oedema—Docetaxel—head and neck cancer	0.000413	0.00433	CcSEcCtD
Indomethacin—Muscular weakness—Fluorouracil—head and neck cancer	0.000412	0.00431	CcSEcCtD
Indomethacin—PPARG—epithelium—head and neck cancer	0.000405	0.00884	CbGeAlD
Indomethacin—Ill-defined disorder—Vinblastine—head and neck cancer	0.000397	0.00416	CcSEcCtD
Indomethacin—Alopecia—Hydroxyurea—head and neck cancer	0.000396	0.00415	CcSEcCtD
Indomethacin—Anaemia—Vinblastine—head and neck cancer	0.000396	0.00415	CcSEcCtD
Indomethacin—Erythema—Hydroxyurea—head and neck cancer	0.00039	0.00409	CcSEcCtD
Indomethacin—Thrombophlebitis—Docetaxel—head and neck cancer	0.000389	0.00408	CcSEcCtD
Indomethacin—Malaise—Vinblastine—head and neck cancer	0.000386	0.00404	CcSEcCtD
Indomethacin—Vertigo—Vinblastine—head and neck cancer	0.000385	0.00403	CcSEcCtD
Indomethacin—Leukopenia—Vinblastine—head and neck cancer	0.000383	0.00401	CcSEcCtD
Indomethacin—Pancytopenia—Fluorouracil—head and neck cancer	0.000383	0.00401	CcSEcCtD
Indomethacin—CES1—thyroid gland—head and neck cancer	0.000383	0.00834	CbGeAlD
Indomethacin—Deafness—Docetaxel—head and neck cancer	0.000376	0.00394	CcSEcCtD
Indomethacin—ABCC1—parotid gland—head and neck cancer	0.000376	0.00819	CbGeAlD
Indomethacin—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000371	0.00389	CcSEcCtD
Indomethacin—Convulsion—Vinblastine—head and neck cancer	0.000371	0.00389	CcSEcCtD
Indomethacin—Hypertension—Vinblastine—head and neck cancer	0.00037	0.00387	CcSEcCtD
Indomethacin—GLO1—lymph node—head and neck cancer	0.000369	0.00804	CbGeAlD
Indomethacin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000362	0.0038	CcSEcCtD
Indomethacin—Anaemia—Hydroxyurea—head and neck cancer	0.000361	0.00378	CcSEcCtD
Indomethacin—Discomfort—Vinblastine—head and neck cancer	0.00036	0.00377	CcSEcCtD
Indomethacin—Hot flush—Docetaxel—head and neck cancer	0.00036	0.00377	CcSEcCtD
Indomethacin—Menopausal symptoms—Docetaxel—head and neck cancer	0.000357	0.00374	CcSEcCtD
Indomethacin—PTGS2—mouth—head and neck cancer	0.000356	0.00776	CbGeAlD
Indomethacin—Renal impairment—Docetaxel—head and neck cancer	0.000354	0.00371	CcSEcCtD
Indomethacin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000352	0.00369	CcSEcCtD
Indomethacin—Malaise—Hydroxyurea—head and neck cancer	0.000352	0.00369	CcSEcCtD
Indomethacin—Stomatitis—Fluorouracil—head and neck cancer	0.000351	0.00367	CcSEcCtD
Indomethacin—Leukopenia—Hydroxyurea—head and neck cancer	0.000349	0.00366	CcSEcCtD
Indomethacin—PLA2G2A—lymph node—head and neck cancer	0.000343	0.00748	CbGeAlD
Indomethacin—Thrombocytopenia—Vinblastine—head and neck cancer	0.000342	0.00358	CcSEcCtD
Indomethacin—CXCL8—lymph node—head and neck cancer	0.00034	0.0074	CbGeAlD
Indomethacin—CES1—head—head and neck cancer	0.00034	0.0074	CbGeAlD
Indomethacin—Epistaxis—Fluorouracil—head and neck cancer	0.000339	0.00355	CcSEcCtD
Indomethacin—Convulsion—Hydroxyurea—head and neck cancer	0.000338	0.00354	CcSEcCtD
Indomethacin—Hyponatraemia—Docetaxel—head and neck cancer	0.000338	0.00354	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000337	0.00353	CcSEcCtD
Indomethacin—Agranulocytosis—Fluorouracil—head and neck cancer	0.000336	0.00352	CcSEcCtD
Indomethacin—Anorexia—Vinblastine—head and neck cancer	0.000333	0.00349	CcSEcCtD
Indomethacin—Discomfort—Hydroxyurea—head and neck cancer	0.000328	0.00344	CcSEcCtD
Indomethacin—Haemoglobin—Fluorouracil—head and neck cancer	0.000324	0.0034	CcSEcCtD
Indomethacin—Haemorrhage—Fluorouracil—head and neck cancer	0.000323	0.00338	CcSEcCtD
Indomethacin—PPARA—lymph node—head and neck cancer	0.00032	0.00698	CbGeAlD
Indomethacin—Oedema—Hydroxyurea—head and neck cancer	0.000319	0.00334	CcSEcCtD
Indomethacin—Paraesthesia—Vinblastine—head and neck cancer	0.000314	0.00329	CcSEcCtD
Indomethacin—PPARG—lymphoid tissue—head and neck cancer	0.000312	0.00681	CbGeAlD
Indomethacin—ABCC3—thyroid gland—head and neck cancer	0.000312	0.0068	CbGeAlD
Indomethacin—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000312	0.00327	CcSEcCtD
Indomethacin—Abdominal pain upper—Docetaxel—head and neck cancer	0.000308	0.00322	CcSEcCtD
Indomethacin—Anorexia—Hydroxyurea—head and neck cancer	0.000304	0.00318	CcSEcCtD
Indomethacin—Decreased appetite—Vinblastine—head and neck cancer	0.000304	0.00318	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000303	0.00318	CcSEcCtD
Indomethacin—Pain—Vinblastine—head and neck cancer	0.000299	0.00313	CcSEcCtD
Indomethacin—Constipation—Vinblastine—head and neck cancer	0.000299	0.00313	CcSEcCtD
Indomethacin—Arrhythmia—Fluorouracil—head and neck cancer	0.000288	0.00302	CcSEcCtD
Indomethacin—Feeling abnormal—Vinblastine—head and neck cancer	0.000288	0.00302	CcSEcCtD
Indomethacin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000286	0.00299	CcSEcCtD
Indomethacin—Alopecia—Fluorouracil—head and neck cancer	0.000285	0.00299	CcSEcCtD
Indomethacin—Dyspnoea—Hydroxyurea—head and neck cancer	0.000284	0.00298	CcSEcCtD
Indomethacin—PPARG—thyroid gland—head and neck cancer	0.000284	0.00618	CbGeAlD
Indomethacin—Somnolence—Hydroxyurea—head and neck cancer	0.000283	0.00297	CcSEcCtD
Indomethacin—Erythema—Fluorouracil—head and neck cancer	0.000281	0.00294	CcSEcCtD
Indomethacin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00028	0.00294	CcSEcCtD
Indomethacin—ABCC1—trachea—head and neck cancer	0.000278	0.00605	CbGeAlD
Indomethacin—Decreased appetite—Hydroxyurea—head and neck cancer	0.000277	0.0029	CcSEcCtD
Indomethacin—ABCC3—head—head and neck cancer	0.000277	0.00603	CbGeAlD
Indomethacin—Pancytopenia—Docetaxel—head and neck cancer	0.000276	0.0029	CcSEcCtD
Indomethacin—Abdominal pain—Vinblastine—head and neck cancer	0.000276	0.00289	CcSEcCtD
Indomethacin—Fatigue—Hydroxyurea—head and neck cancer	0.000275	0.00288	CcSEcCtD
Indomethacin—Pain—Hydroxyurea—head and neck cancer	0.000272	0.00285	CcSEcCtD
Indomethacin—Constipation—Hydroxyurea—head and neck cancer	0.000272	0.00285	CcSEcCtD
Indomethacin—AKR1C3—lymph node—head and neck cancer	0.000266	0.0058	CbGeAlD
Indomethacin—Weight increased—Docetaxel—head and neck cancer	0.000265	0.00278	CcSEcCtD
Indomethacin—Vision blurred—Fluorouracil—head and neck cancer	0.000265	0.00277	CcSEcCtD
Indomethacin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000263	0.00275	CcSEcCtD
Indomethacin—Anaemia—Fluorouracil—head and neck cancer	0.00026	0.00272	CcSEcCtD
Indomethacin—ABCC4—thyroid gland—head and neck cancer	0.000258	0.00561	CbGeAlD
Indomethacin—Hypersensitivity—Vinblastine—head and neck cancer	0.000257	0.0027	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000257	0.0027	CcSEcCtD
Indomethacin—Renal failure—Docetaxel—head and neck cancer	0.000255	0.00267	CcSEcCtD
Indomethacin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000254	0.00267	CcSEcCtD
Indomethacin—Stomatitis—Docetaxel—head and neck cancer	0.000253	0.00265	CcSEcCtD
Indomethacin—Jaundice—Docetaxel—head and neck cancer	0.000253	0.00265	CcSEcCtD
Indomethacin—Body temperature increased—Hydroxyurea—head and neck cancer	0.000252	0.00264	CcSEcCtD
Indomethacin—PPARG—head—head and neck cancer	0.000252	0.00548	CbGeAlD
Indomethacin—Leukopenia—Fluorouracil—head and neck cancer	0.000252	0.00264	CcSEcCtD
Indomethacin—Asthenia—Vinblastine—head and neck cancer	0.000251	0.00263	CcSEcCtD
Indomethacin—Epistaxis—Docetaxel—head and neck cancer	0.000245	0.00256	CcSEcCtD
Indomethacin—Convulsion—Fluorouracil—head and neck cancer	0.000243	0.00255	CcSEcCtD
Indomethacin—Agranulocytosis—Docetaxel—head and neck cancer	0.000242	0.00254	CcSEcCtD
Indomethacin—Chest pain—Fluorouracil—head and neck cancer	0.000239	0.00251	CcSEcCtD
Indomethacin—Diarrhoea—Vinblastine—head and neck cancer	0.000239	0.0025	CcSEcCtD
Indomethacin—CES1—lymph node—head and neck cancer	0.000238	0.00518	CbGeAlD
Indomethacin—SLCO1A2—head—head and neck cancer	0.000237	0.00517	CbGeAlD
Indomethacin—Discomfort—Fluorouracil—head and neck cancer	0.000236	0.00248	CcSEcCtD
Indomethacin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000235	0.00246	CcSEcCtD
Indomethacin—Haemoglobin—Docetaxel—head and neck cancer	0.000234	0.00245	CcSEcCtD
Indomethacin—Haemorrhage—Docetaxel—head and neck cancer	0.000233	0.00244	CcSEcCtD
Indomethacin—Hepatitis—Docetaxel—head and neck cancer	0.000233	0.00244	CcSEcCtD
Indomethacin—Confusional state—Fluorouracil—head and neck cancer	0.000231	0.00242	CcSEcCtD
Indomethacin—Dizziness—Vinblastine—head and neck cancer	0.000231	0.00242	CcSEcCtD
Indomethacin—Oedema—Fluorouracil—head and neck cancer	0.000229	0.0024	CcSEcCtD
Indomethacin—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000229	0.0024	CcSEcCtD
Indomethacin—Asthenia—Hydroxyurea—head and neck cancer	0.000229	0.0024	CcSEcCtD
Indomethacin—ABCC4—head—head and neck cancer	0.000228	0.00498	CbGeAlD
Indomethacin—PTGS1—connective tissue—head and neck cancer	0.000228	0.00498	CbGeAlD
Indomethacin—SLC22A8—head—head and neck cancer	0.000227	0.00494	CbGeAlD
Indomethacin—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000225	0.00235	CcSEcCtD
Indomethacin—Tachycardia—Fluorouracil—head and neck cancer	0.000224	0.00235	CcSEcCtD
Indomethacin—Vomiting—Vinblastine—head and neck cancer	0.000222	0.00233	CcSEcCtD
Indomethacin—Erythema multiforme—Docetaxel—head and neck cancer	0.00022	0.00231	CcSEcCtD
Indomethacin—ABCC1—thyroid gland—head and neck cancer	0.00022	0.00479	CbGeAlD
Indomethacin—Headache—Vinblastine—head and neck cancer	0.000219	0.00229	CcSEcCtD
Indomethacin—Anorexia—Fluorouracil—head and neck cancer	0.000219	0.00229	CcSEcCtD
Indomethacin—PTGS2—connective tissue—head and neck cancer	0.000218	0.00476	CbGeAlD
Indomethacin—Diarrhoea—Hydroxyurea—head and neck cancer	0.000218	0.00228	CcSEcCtD
Indomethacin—PTGS1—epithelium—head and neck cancer	0.000217	0.00472	CbGeAlD
Indomethacin—Flushing—Docetaxel—head and neck cancer	0.000216	0.00227	CcSEcCtD
Indomethacin—Hypotension—Fluorouracil—head and neck cancer	0.000214	0.00225	CcSEcCtD
Indomethacin—Dizziness—Hydroxyurea—head and neck cancer	0.000211	0.00221	CcSEcCtD
Indomethacin—Arrhythmia—Docetaxel—head and neck cancer	0.000208	0.00218	CcSEcCtD
Indomethacin—Nausea—Vinblastine—head and neck cancer	0.000208	0.00217	CcSEcCtD
Indomethacin—Insomnia—Fluorouracil—head and neck cancer	0.000207	0.00217	CcSEcCtD
Indomethacin—PTGS2—epithelium—head and neck cancer	0.000207	0.00452	CbGeAlD
Indomethacin—Paraesthesia—Fluorouracil—head and neck cancer	0.000206	0.00216	CcSEcCtD
Indomethacin—Alopecia—Docetaxel—head and neck cancer	0.000206	0.00216	CcSEcCtD
Indomethacin—Dyspnoea—Fluorouracil—head and neck cancer	0.000204	0.00214	CcSEcCtD
Indomethacin—Somnolence—Fluorouracil—head and neck cancer	0.000204	0.00214	CcSEcCtD
Indomethacin—Erythema—Docetaxel—head and neck cancer	0.000203	0.00212	CcSEcCtD
Indomethacin—Vomiting—Hydroxyurea—head and neck cancer	0.000203	0.00212	CcSEcCtD
Indomethacin—Dyspepsia—Fluorouracil—head and neck cancer	0.000202	0.00212	CcSEcCtD
Indomethacin—Rash—Hydroxyurea—head and neck cancer	0.000201	0.0021	CcSEcCtD
Indomethacin—Dermatitis—Hydroxyurea—head and neck cancer	0.000201	0.0021	CcSEcCtD
Indomethacin—Headache—Hydroxyurea—head and neck cancer	0.0002	0.00209	CcSEcCtD
Indomethacin—Decreased appetite—Fluorouracil—head and neck cancer	0.000199	0.00209	CcSEcCtD
Indomethacin—Pain—Fluorouracil—head and neck cancer	0.000196	0.00205	CcSEcCtD
Indomethacin—ABCC3—lymph node—head and neck cancer	0.000194	0.00422	CbGeAlD
Indomethacin—PTGS1—trachea—head and neck cancer	0.000192	0.00418	CbGeAlD
Indomethacin—Nausea—Hydroxyurea—head and neck cancer	0.000189	0.00198	CcSEcCtD
Indomethacin—Feeling abnormal—Fluorouracil—head and neck cancer	0.000189	0.00198	CcSEcCtD
Indomethacin—Anaemia—Docetaxel—head and neck cancer	0.000187	0.00196	CcSEcCtD
Indomethacin—PTGS2—trachea—head and neck cancer	0.000183	0.00399	CbGeAlD
Indomethacin—Urticaria—Fluorouracil—head and neck cancer	0.000182	0.00191	CcSEcCtD
Indomethacin—Syncope—Docetaxel—head and neck cancer	0.000182	0.00191	CcSEcCtD
Indomethacin—Leukopenia—Docetaxel—head and neck cancer	0.000182	0.0019	CcSEcCtD
Indomethacin—Body temperature increased—Fluorouracil—head and neck cancer	0.000181	0.0019	CcSEcCtD
Indomethacin—Palpitations—Docetaxel—head and neck cancer	0.000179	0.00188	CcSEcCtD
Indomethacin—Loss of consciousness—Docetaxel—head and neck cancer	0.000178	0.00187	CcSEcCtD
Indomethacin—PPARG—lymph node—head and neck cancer	0.000176	0.00384	CbGeAlD
Indomethacin—Convulsion—Docetaxel—head and neck cancer	0.000176	0.00184	CcSEcCtD
Indomethacin—Hypertension—Docetaxel—head and neck cancer	0.000175	0.00183	CcSEcCtD
Indomethacin—Chest pain—Docetaxel—head and neck cancer	0.000173	0.00181	CcSEcCtD
Indomethacin—Hypersensitivity—Fluorouracil—head and neck cancer	0.000169	0.00177	CcSEcCtD
Indomethacin—Confusional state—Docetaxel—head and neck cancer	0.000167	0.00175	CcSEcCtD
Indomethacin—Anaphylactic shock—Docetaxel—head and neck cancer	0.000166	0.00173	CcSEcCtD
Indomethacin—Oedema—Docetaxel—head and neck cancer	0.000166	0.00173	CcSEcCtD
Indomethacin—ALB—lymph node—head and neck cancer	0.000165	0.0036	CbGeAlD
Indomethacin—Shock—Docetaxel—head and neck cancer	0.000163	0.00171	CcSEcCtD
Indomethacin—Pruritus—Fluorouracil—head and neck cancer	0.000162	0.0017	CcSEcCtD
Indomethacin—Thrombocytopenia—Docetaxel—head and neck cancer	0.000162	0.0017	CcSEcCtD
Indomethacin—Tachycardia—Docetaxel—head and neck cancer	0.000162	0.00169	CcSEcCtD
Indomethacin—ABCC4—lymph node—head and neck cancer	0.00016	0.00349	CbGeAlD
Indomethacin—PTGS2—lymphoid tissue—head and neck cancer	0.00016	0.00348	CbGeAlD
Indomethacin—Anorexia—Docetaxel—head and neck cancer	0.000158	0.00165	CcSEcCtD
Indomethacin—Diarrhoea—Fluorouracil—head and neck cancer	0.000157	0.00164	CcSEcCtD
Indomethacin—ABCC2—lymph node—head and neck cancer	0.000155	0.00337	CbGeAlD
Indomethacin—Hypotension—Docetaxel—head and neck cancer	0.000155	0.00162	CcSEcCtD
Indomethacin—Dizziness—Fluorouracil—head and neck cancer	0.000152	0.00159	CcSEcCtD
Indomethacin—PTGS1—thyroid gland—head and neck cancer	0.000152	0.0033	CbGeAlD
Indomethacin—Insomnia—Docetaxel—head and neck cancer	0.00015	0.00157	CcSEcCtD
Indomethacin—Paraesthesia—Docetaxel—head and neck cancer	0.000149	0.00156	CcSEcCtD
Indomethacin—Dyspnoea—Docetaxel—head and neck cancer	0.000148	0.00155	CcSEcCtD
Indomethacin—Somnolence—Docetaxel—head and neck cancer	0.000147	0.00154	CcSEcCtD
Indomethacin—Vomiting—Fluorouracil—head and neck cancer	0.000146	0.00153	CcSEcCtD
Indomethacin—Dyspepsia—Docetaxel—head and neck cancer	0.000146	0.00153	CcSEcCtD
Indomethacin—Rash—Fluorouracil—head and neck cancer	0.000145	0.00152	CcSEcCtD
Indomethacin—Dermatitis—Fluorouracil—head and neck cancer	0.000144	0.00151	CcSEcCtD
Indomethacin—Decreased appetite—Docetaxel—head and neck cancer	0.000144	0.00151	CcSEcCtD
Indomethacin—Headache—Fluorouracil—head and neck cancer	0.000144	0.00151	CcSEcCtD
Indomethacin—Fatigue—Docetaxel—head and neck cancer	0.000143	0.0015	CcSEcCtD
Indomethacin—Constipation—Docetaxel—head and neck cancer	0.000142	0.00148	CcSEcCtD
Indomethacin—Pain—Docetaxel—head and neck cancer	0.000142	0.00148	CcSEcCtD
Indomethacin—Feeling abnormal—Docetaxel—head and neck cancer	0.000136	0.00143	CcSEcCtD
Indomethacin—ABCC1—lymph node—head and neck cancer	0.000136	0.00297	CbGeAlD
Indomethacin—Nausea—Fluorouracil—head and neck cancer	0.000136	0.00143	CcSEcCtD
Indomethacin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000135	0.00142	CcSEcCtD
Indomethacin—PTGS1—head—head and neck cancer	0.000135	0.00293	CbGeAlD
Indomethacin—Abdominal pain—Docetaxel—head and neck cancer	0.000131	0.00137	CcSEcCtD
Indomethacin—Body temperature increased—Docetaxel—head and neck cancer	0.000131	0.00137	CcSEcCtD
Indomethacin—PTGS2—head—head and neck cancer	0.000129	0.0028	CbGeAlD
Indomethacin—ABCB1—epithelium—head and neck cancer	0.000128	0.00279	CbGeAlD
Indomethacin—Hypersensitivity—Docetaxel—head and neck cancer	0.000122	0.00128	CcSEcCtD
Indomethacin—Asthenia—Docetaxel—head and neck cancer	0.000119	0.00124	CcSEcCtD
Indomethacin—Pruritus—Docetaxel—head and neck cancer	0.000117	0.00123	CcSEcCtD
Indomethacin—ABCB1—trachea—head and neck cancer	0.000113	0.00247	CbGeAlD
Indomethacin—Diarrhoea—Docetaxel—head and neck cancer	0.000113	0.00119	CcSEcCtD
Indomethacin—Dizziness—Docetaxel—head and neck cancer	0.000109	0.00115	CcSEcCtD
Indomethacin—Vomiting—Docetaxel—head and neck cancer	0.000105	0.0011	CcSEcCtD
Indomethacin—Rash—Docetaxel—head and neck cancer	0.000104	0.00109	CcSEcCtD
Indomethacin—Dermatitis—Docetaxel—head and neck cancer	0.000104	0.00109	CcSEcCtD
Indomethacin—Headache—Docetaxel—head and neck cancer	0.000104	0.00109	CcSEcCtD
Indomethacin—ABCB1—lymphoid tissue—head and neck cancer	9.87e-05	0.00215	CbGeAlD
Indomethacin—Nausea—Docetaxel—head and neck cancer	9.83e-05	0.00103	CcSEcCtD
Indomethacin—PTGS1—lymph node—head and neck cancer	9.42e-05	0.00205	CbGeAlD
Indomethacin—PTGS2—lymph node—head and neck cancer	9e-05	0.00196	CbGeAlD
Indomethacin—ABCB1—thyroid gland—head and neck cancer	8.96e-05	0.00195	CbGeAlD
Indomethacin—ABCB1—head—head and neck cancer	7.95e-05	0.00173	CbGeAlD
Indomethacin—ABCB1—lymph node—head and neck cancer	5.57e-05	0.00121	CbGeAlD
Indomethacin—PPARG—Metabolism—GPX1—head and neck cancer	1.5e-05	0.000155	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	1.5e-05	0.000155	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.49e-05	0.000154	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—CYP1A1—head and neck cancer	1.48e-05	0.000153	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—PIK3CA—head and neck cancer	1.48e-05	0.000153	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PTEN—head and neck cancer	1.48e-05	0.000153	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.47e-05	0.000152	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL2—head and neck cancer	1.47e-05	0.000152	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—YAP1—head and neck cancer	1.47e-05	0.000152	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—TYMS—head and neck cancer	1.46e-05	0.000151	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GSTM1—head and neck cancer	1.44e-05	0.000149	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PTEN—head and neck cancer	1.44e-05	0.000149	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.43e-05	0.000148	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—head and neck cancer	1.43e-05	0.000148	CbGpPWpGaD
Indomethacin—ALB—Metabolism—NAT2—head and neck cancer	1.43e-05	0.000147	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTGS2—head and neck cancer	1.42e-05	0.000147	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	1.42e-05	0.000146	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.39e-05	0.000144	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.39e-05	0.000144	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—GPX1—head and neck cancer	1.38e-05	0.000143	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HRAS—head and neck cancer	1.37e-05	0.000142	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—CYP1A1—head and neck cancer	1.37e-05	0.000141	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—TYMS—head and neck cancer	1.36e-05	0.000141	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—TYMS—head and neck cancer	1.36e-05	0.000141	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.36e-05	0.000141	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.36e-05	0.000141	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	1.35e-05	0.000139	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.35e-05	0.000139	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GSTM1—head and neck cancer	1.35e-05	0.000139	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GSTM1—head and neck cancer	1.35e-05	0.000139	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—PIK3CA—head and neck cancer	1.33e-05	0.000138	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.33e-05	0.000137	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.33e-05	0.000137	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.33e-05	0.000137	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—STAT3—head and neck cancer	1.32e-05	0.000137	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—TYMS—head and neck cancer	1.31e-05	0.000136	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GSTM1—head and neck cancer	1.3e-05	0.000134	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.29e-05	0.000133	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—GPX1—head and neck cancer	1.29e-05	0.000133	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—GPX1—head and neck cancer	1.29e-05	0.000133	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—head and neck cancer	1.29e-05	0.000133	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—NAT2—head and neck cancer	1.28e-05	0.000132	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—CYP1A1—head and neck cancer	1.28e-05	0.000132	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—CYP1A1—head and neck cancer	1.28e-05	0.000132	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MAPK3—head and neck cancer	1.26e-05	0.000131	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—HRAS—head and neck cancer	1.26e-05	0.000131	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NOTCH1—head and neck cancer	1.26e-05	0.00013	CbGpPWpGaD
Indomethacin—ALB—Metabolism—DPYD—head and neck cancer	1.25e-05	0.000129	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—NAT2—head and neck cancer	1.25e-05	0.000129	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—TYMS—head and neck cancer	1.25e-05	0.000129	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—GPX1—head and neck cancer	1.24e-05	0.000128	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.24e-05	0.000128	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PTEN—head and neck cancer	1.24e-05	0.000128	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GSTM1—head and neck cancer	1.23e-05	0.000127	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—HRAS—head and neck cancer	1.23e-05	0.000127	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTGS2—head and neck cancer	1.23e-05	0.000127	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.23e-05	0.000127	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.23e-05	0.000127	CbGpPWpGaD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.22e-05	0.000126	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.21e-05	0.000125	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—AKT1—head and neck cancer	1.21e-05	0.000125	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MAPK1—head and neck cancer	1.2e-05	0.000124	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EGFR—head and neck cancer	1.2e-05	0.000124	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—PIK3CA—head and neck cancer	1.2e-05	0.000124	CbGpPWpGaD
Indomethacin—ALB—Metabolism—YAP1—head and neck cancer	1.19e-05	0.000123	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—MAPK3—head and neck cancer	1.18e-05	0.000122	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—GPX1—head and neck cancer	1.18e-05	0.000122	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—MAPK3—head and neck cancer	1.18e-05	0.000122	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NOTCH1—head and neck cancer	1.18e-05	0.000122	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.17e-05	0.000121	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	1.17e-05	0.000121	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—NAT2—head and neck cancer	1.17e-05	0.000121	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.15e-05	0.000119	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—MAPK1—head and neck cancer	1.12e-05	0.000116	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—EGFR—head and neck cancer	1.12e-05	0.000116	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.12e-05	0.000116	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—DPYD—head and neck cancer	1.12e-05	0.000116	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—AKT1—head and neck cancer	1.12e-05	0.000115	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.11e-05	0.000115	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—TYMS—head and neck cancer	1.11e-05	0.000115	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2—head and neck cancer	1.1e-05	0.000114	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GSTM1—head and neck cancer	1.1e-05	0.000113	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—DPYD—head and neck cancer	1.1e-05	0.000113	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—AKT1—head and neck cancer	1.09e-05	0.000112	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—PIK3CA—head and neck cancer	1.07e-05	0.000111	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PTEN—head and neck cancer	1.07e-05	0.000111	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCND1—head and neck cancer	1.07e-05	0.000111	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—YAP1—head and neck cancer	1.07e-05	0.00011	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—GPX1—head and neck cancer	1.05e-05	0.000109	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.05e-05	0.000108	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PIK3CA—head and neck cancer	1.04e-05	0.000108	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—YAP1—head and neck cancer	1.04e-05	0.000108	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—CYP1A1—head and neck cancer	1.04e-05	0.000108	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PTEN—head and neck cancer	1.04e-05	0.000107	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—DPYD—head and neck cancer	1.02e-05	0.000106	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—PIK3CA—head and neck cancer	1.02e-05	0.000105	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.01e-05	0.000104	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism—AKT1—head and neck cancer	9.76e-06	0.000101	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—PIK3CA—head and neck cancer	9.76e-06	0.000101	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—YAP1—head and neck cancer	9.71e-06	0.0001	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—head and neck cancer	9.65e-06	9.98e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.61e-06	9.94e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.6e-06	9.93e-05	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	9.55e-06	9.87e-05	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	9.4e-06	9.72e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—head and neck cancer	9.36e-06	9.67e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTGS2—head and neck cancer	9.33e-06	9.65e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTGS2—head and neck cancer	9.33e-06	9.65e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STAT3—head and neck cancer	9.26e-06	9.58e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2—head and neck cancer	9.08e-06	9.39e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—head and neck cancer	9.03e-06	9.33e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.92e-06	9.22e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK3—head and neck cancer	8.85e-06	9.15e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTGS2—head and neck cancer	8.83e-06	9.13e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—TYMS—head and neck cancer	8.81e-06	9.11e-05	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—AKT1—head and neck cancer	8.78e-06	9.08e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PIK3CA—head and neck cancer	8.74e-06	9.04e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTGS2—head and neck cancer	8.73e-06	9.03e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GSTM1—head and neck cancer	8.71e-06	9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2—head and neck cancer	8.68e-06	8.98e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	8.54e-06	8.83e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—AKT1—head and neck cancer	8.53e-06	8.81e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—head and neck cancer	8.47e-06	8.75e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MAPK3—head and neck cancer	8.46e-06	8.75e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MAPK1—head and neck cancer	8.42e-06	8.71e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—head and neck cancer	8.42e-06	8.71e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—GPX1—head and neck cancer	8.34e-06	8.62e-05	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—AKT1—head and neck cancer	8.3e-06	8.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—CYP1A1—head and neck cancer	8.25e-06	8.53e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PTEN—head and neck cancer	8.17e-06	8.45e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PTEN—head and neck cancer	8.14e-06	8.42e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PTEN—head and neck cancer	8.14e-06	8.42e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTGS2—head and neck cancer	8.13e-06	8.4e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8e-06	8.28e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—AKT1—head and neck cancer	7.97e-06	8.24e-05	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—AKT1—head and neck cancer	7.96e-06	8.23e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NOTCH1—head and neck cancer	7.89e-06	8.16e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.78e-06	8.04e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—head and neck cancer	7.72e-06	7.98e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PTEN—head and neck cancer	7.7e-06	7.96e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PTEN—head and neck cancer	7.62e-06	7.87e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTGS2—head and neck cancer	7.58e-06	7.84e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTGS2—head and neck cancer	7.58e-06	7.84e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PIK3CA—head and neck cancer	7.58e-06	7.83e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—head and neck cancer	7.38e-06	7.63e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTGS2—head and neck cancer	7.31e-06	7.56e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PIK3CA—head and neck cancer	7.31e-06	7.56e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STAT3—head and neck cancer	7.31e-06	7.56e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.3e-06	7.55e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK3—head and neck cancer	7.3e-06	7.55e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—AKT1—head and neck cancer	7.14e-06	7.38e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—TYMS—head and neck cancer	7.13e-06	7.37e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PTEN—head and neck cancer	7.09e-06	7.33e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—head and neck cancer	7.07e-06	7.31e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GSTM1—head and neck cancer	7.04e-06	7.28e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK3—head and neck cancer	6.98e-06	7.22e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.98e-06	7.22e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTGS2—head and neck cancer	6.95e-06	7.19e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—MAPK1—head and neck cancer	6.94e-06	7.18e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—STAT3—head and neck cancer	6.81e-06	7.04e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.78e-06	7.01e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—head and neck cancer	6.76e-06	6.99e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—GPX1—head and neck cancer	6.75e-06	6.97e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—CYP1A1—head and neck cancer	6.68e-06	6.9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MAPK1—head and neck cancer	6.64e-06	6.87e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—head and neck cancer	6.64e-06	6.87e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PTEN—head and neck cancer	6.61e-06	6.84e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PTEN—head and neck cancer	6.61e-06	6.84e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK3—head and neck cancer	6.51e-06	6.73e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—TYMS—head and neck cancer	6.4e-06	6.61e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PTEN—head and neck cancer	6.38e-06	6.6e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.37e-06	6.58e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GSTM1—head and neck cancer	6.32e-06	6.54e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—TYMS—head and neck cancer	6.24e-06	6.46e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MAPK1—head and neck cancer	6.19e-06	6.4e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—head and neck cancer	6.19e-06	6.4e-05	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—AKT1—head and neck cancer	6.19e-06	6.4e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTGS2—head and neck cancer	6.18e-06	6.39e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GSTM1—head and neck cancer	6.17e-06	6.38e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PTEN—head and neck cancer	6.06e-06	6.27e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—GPX1—head and neck cancer	6.06e-06	6.26e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PIK3CA—head and neck cancer	6.03e-06	6.23e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—CYP1A1—head and neck cancer	5.99e-06	6.2e-05	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—AKT1—head and neck cancer	5.97e-06	6.17e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—GPX1—head and neck cancer	5.91e-06	6.11e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—CYP1A1—head and neck cancer	5.85e-06	6.05e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—TYMS—head and neck cancer	5.83e-06	6.03e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—head and neck cancer	5.83e-06	6.03e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GSTM1—head and neck cancer	5.77e-06	5.96e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PIK3CA—head and neck cancer	5.76e-06	5.96e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PIK3CA—head and neck cancer	5.74e-06	5.94e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PIK3CA—head and neck cancer	5.74e-06	5.94e-05	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—AKT1—head and neck cancer	5.71e-06	5.9e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—head and neck cancer	5.58e-06	5.77e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—head and neck cancer	5.58e-06	5.76e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—GPX1—head and neck cancer	5.52e-06	5.71e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.49e-06	5.67e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—CYP1A1—head and neck cancer	5.47e-06	5.65e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PIK3CA—head and neck cancer	5.43e-06	5.61e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PTEN—head and neck cancer	5.39e-06	5.58e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PIK3CA—head and neck cancer	5.37e-06	5.56e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—head and neck cancer	5.33e-06	5.51e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PTEN—head and neck cancer	5.11e-06	5.29e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PIK3CA—head and neck cancer	5e-06	5.17e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—head and neck cancer	4.97e-06	5.14e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.92e-06	5.09e-05	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—AKT1—head and neck cancer	4.92e-06	5.09e-05	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—AKT1—head and neck cancer	4.71e-06	4.87e-05	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—AKT1—head and neck cancer	4.69e-06	4.85e-05	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—AKT1—head and neck cancer	4.69e-06	4.85e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PIK3CA—head and neck cancer	4.67e-06	4.83e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PIK3CA—head and neck cancer	4.67e-06	4.83e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—STAT3—head and neck cancer	4.57e-06	4.73e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PIK3CA—head and neck cancer	4.5e-06	4.65e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.49e-06	4.64e-05	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—AKT1—head and neck cancer	4.44e-06	4.59e-05	CbGpPWpGaD
Indomethacin—ABCC1—Disease—AKT1—head and neck cancer	4.39e-06	4.54e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK3—head and neck cancer	4.37e-06	4.52e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PTEN—head and neck cancer	4.28e-06	4.43e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	4.28e-06	4.42e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MAPK1—head and neck cancer	4.16e-06	4.3e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—head and neck cancer	4.15e-06	4.3e-05	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—AKT1—head and neck cancer	4.09e-06	4.22e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTGS2—head and neck cancer	3.97e-06	4.11e-05	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—AKT1—head and neck cancer	3.81e-06	3.94e-05	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—AKT1—head and neck cancer	3.81e-06	3.94e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PIK3CA—head and neck cancer	3.8e-06	3.93e-05	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—AKT1—head and neck cancer	3.68e-06	3.8e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PIK3CA—head and neck cancer	3.61e-06	3.73e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTGS2—head and neck cancer	3.56e-06	3.69e-05	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—AKT1—head and neck cancer	3.49e-06	3.61e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTGS2—head and neck cancer	3.48e-06	3.6e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PTEN—head and neck cancer	3.46e-06	3.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—head and neck cancer	3.34e-06	3.45e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.25e-06	3.36e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PTEN—head and neck cancer	3.11e-06	3.21e-05	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—AKT1—head and neck cancer	3.11e-06	3.21e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PTEN—head and neck cancer	3.03e-06	3.14e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PIK3CA—head and neck cancer	3.02e-06	3.12e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—AKT1—head and neck cancer	2.95e-06	3.05e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PTEN—head and neck cancer	2.83e-06	2.93e-05	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—AKT1—head and neck cancer	2.47e-06	2.55e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PIK3CA—head and neck cancer	2.44e-06	2.53e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.19e-06	2.27e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.14e-06	2.21e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PIK3CA—head and neck cancer	2e-06	2.07e-05	CbGpPWpGaD
Indomethacin—ALB—Metabolism—AKT1—head and neck cancer	2e-06	2.06e-05	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—AKT1—head and neck cancer	1.79e-06	1.85e-05	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—AKT1—head and neck cancer	1.75e-06	1.81e-05	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—AKT1—head and neck cancer	1.63e-06	1.69e-05	CbGpPWpGaD
